IL166633A0 - Methods and reagents relating to inflammation and apoptosis - Google Patents

Methods and reagents relating to inflammation and apoptosis

Info

Publication number
IL166633A0
IL166633A0 IL16663305A IL16663305A IL166633A0 IL 166633 A0 IL166633 A0 IL 166633A0 IL 16663305 A IL16663305 A IL 16663305A IL 16663305 A IL16663305 A IL 16663305A IL 166633 A0 IL166633 A0 IL 166633A0
Authority
IL
Israel
Prior art keywords
apoptosis
inflammation
methods
reagents relating
reagents
Prior art date
Application number
IL16663305A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of IL166633A0 publication Critical patent/IL166633A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL16663305A 2002-08-01 2005-02-01 Methods and reagents relating to inflammation and apoptosis IL166633A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40041002P 2002-08-01 2002-08-01
PCT/US2003/024340 WO2004012673A2 (en) 2002-08-01 2003-08-01 Methods and reagents relating to inflammation and apoptosis

Publications (1)

Publication Number Publication Date
IL166633A0 true IL166633A0 (en) 2006-01-15

Family

ID=31495819

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16663305A IL166633A0 (en) 2002-08-01 2005-02-01 Methods and reagents relating to inflammation and apoptosis

Country Status (10)

Country Link
US (1) US20060078944A1 (xx)
EP (1) EP1542722A4 (xx)
JP (1) JP2006509724A (xx)
CN (1) CN1700930A (xx)
AU (1) AU2003258036A1 (xx)
BR (1) BR0313151A (xx)
CA (1) CA2494276A1 (xx)
IL (1) IL166633A0 (xx)
MX (1) MXPA05001268A (xx)
WO (1) WO2004012673A2 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1558640B1 (en) * 2002-10-29 2011-04-13 Anaphore, Inc. Trimeric binding proteins for trimeric cytokines
CA2540775A1 (en) * 2003-10-02 2005-04-21 Xantos Biomedicine Ag Medical use of tbk-1 or of inhibitors thereof
US20090232808A1 (en) * 2005-01-28 2009-09-17 Apollo Life Sciences Limited Molecules and chimeric molecules thereof
CA2764164A1 (en) 2009-06-05 2010-12-09 13Therapeutics, Inc. Immunoregulatory peptides and methods of use
CA2778454C (en) 2009-10-26 2021-03-02 Prometheus Laboratories Inc. Assays for the detection of anti-tnf drugs and autoantibodies
JP5960707B2 (ja) 2010-10-18 2016-08-02 ネステク ソシエテ アノニム 抗薬物抗体アイソタイプを決定するための方法
CN106046144B (zh) * 2011-05-07 2020-01-10 姜石松 与凋亡或坏死相关的TNFα短肽及其应用
CN103782172A (zh) 2011-07-06 2014-05-07 雀巢产品技术援助有限公司 检测针对使用TNFα的生物疗法的中和性自体抗体的测定法
AU2015356613A1 (en) 2014-12-05 2017-06-15 Société des Produits Nestlé S.A. Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
CN104987380B (zh) * 2015-06-02 2018-05-18 上海英邈生物科技有限公司 一种检测血浆炎性细胞因子自身抗体的组合物、试剂盒与方法
GB201510758D0 (en) 2015-06-18 2015-08-05 Ucb Biopharma Sprl Novel TNFa structure for use in therapy
GB201621907D0 (en) 2016-12-21 2017-02-01 Ucb Biopharma Sprl And Sanofi Antibody epitope

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106271A (en) * 1992-09-03 2008-03-20 Yeda Res & Dev Ligand to TNF 75P receptor and its preparation
DE4006269A1 (de) * 1990-02-28 1991-08-29 Max Planck Gesellschaft Antikoerper gegen den tumor-nekrosefaktor-rezeptor
ZA966663B (en) * 1995-08-17 1998-02-06 Genentech Inc Traf Inhibitors.
US5837514A (en) * 1997-03-07 1998-11-17 Tularik Inc. IκB kinases
US6365366B1 (en) * 2000-03-13 2002-04-02 Tularik Inc. T2k kinase assays

Also Published As

Publication number Publication date
CN1700930A (zh) 2005-11-23
US20060078944A1 (en) 2006-04-13
EP1542722A2 (en) 2005-06-22
MXPA05001268A (es) 2005-10-06
EP1542722A4 (en) 2006-02-01
WO2004012673A3 (en) 2004-07-15
BR0313151A (pt) 2007-07-17
CA2494276A1 (en) 2004-02-12
WO2004012673A2 (en) 2004-02-12
AU2003258036A1 (en) 2004-02-23
JP2006509724A (ja) 2006-03-23

Similar Documents

Publication Publication Date Title
IL166633A0 (en) Methods and reagents relating to inflammation and apoptosis
GB0212551D0 (en) Improvements in and relating to optical devices
AU2003249350A8 (en) Electrochemiluminescence flow cell and flow cell components
EP1511408A4 (en) BACKPACK WITH WHEELS
GB0218652D0 (en) Improvements in or relating to stairlifts
GB2394077B (en) Consumption meter
GB2409389B (en) Signal processors and associated methods
GB0303228D0 (en) Gel
GB2410209B (en) Improvements in or relating to devices
AU2003211088A1 (en) Led display and method to create same
GB0226418D0 (en) Improvements in or relating to stairlifts
GB2391539B (en) Improvement in or relating to stairlifts
GB0213979D0 (en) Improvements in and relating to analysis
AU2003302173A8 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003265658A8 (en) Systems and methods to support import-export transactions
GB0320833D0 (en) Improvements in and relating to lighting systems
HK1047384A2 (en) Calculator with liquid ornament
GB0217967D0 (en) TO be decided
GB0208853D0 (en) An antibody specific to CD14 and uses thereof
GB2387487B (en) Improvements in and relating to trunking
GB0215924D0 (en) Improvements in or relating to lighting systems
GB0203998D0 (en) Materials and methods relating to cancer diagnosis
GB0226592D0 (en) Materials and methods relating to cancer diagnosis
GB0214030D0 (en) Run and root
GB0207649D0 (en) Improvement in or relating to passarelles